Jinqiu Wang

This inventor holds 5 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Crystal Pharmaceutical (Suzhou) Co., Ltd., Glaxosmithkline Intellectual Property (No.2) Limited, Crystal Pharmatech Co., Ltd.. Active years: 2019-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jinqiu Wang. Retrieved from https://idiyas.com/inventor/jinqiu-wang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 (Patent Applications = 2)

% Patents Active = 60.0

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 3 (Patent Applications = 4)

Average Co-Inventor Count = 4.7

ph-index = 1

Forward Citations = 4(Granted Patents)

Company Filing History:

2 out of 20

Crystal Pharmaceutical (Suzhou) Co., Ltd.

patents

2 out of 95

Glaxosmithkline Intellectual Property (No.2) Limited

patents

1 out of 22

Crystal Pharmatech Co., Ltd.

patents

Years Active: 2019-2023

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11649217 - Crystalline forms of GSK1278863, preparation method and pharmaceutical use thereof (2023-05-16),

2. 11117871 - Crystalline forms of GSK1278863, preparation method and pharmaceutical use thereof (2021-09-14),

3. 10703724 - Crystalline forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl] amino} acetic acid and processes for preparation thereof (2020-07-07),

4. 10544129 - Crystalline forms of AP26113, and preparation method thereof (2020-01-28),

5. 10442800 - Crystal forms of NBI-98854, preparation method and use thereof (2019-10-15),

Title: The Innovative Mind of Jinqiu Wang in Pharmaceutical Science

Introduction

Jinqiu Wang, a prominent inventor based in Suzhou, China, has made significant contributions to the field of pharmaceutical science. With a strong portfolio of five patents, his work primarily focuses on advancements in the treatment of anemia through innovative compounds.

Latest Patents

Among his latest patents are notable innovations concerning the crystalline forms of GSK1278863. These patents detail the preparation methods and pharmaceutical applications of crystalline forms CS1 and CS9 of a hypoxia-inducible factor prolyl hydroxylase inhibitor compound known as GSK1278863. These crystalline forms are vital for developing drugs aimed at treating and preventing anemia, showcasing Wang's dedication to improving patient care through pharmaceutical innovation.

Career Highlights

Throughout his career, Jinqiu Wang has worked with esteemed organizations such as Crystal Pharmaceutical (Suzhou) Co., Ltd., and GlaxoSmithKline Intellectual Property (No.2) Limited. His professional experience at these companies has greatly influenced his inventive pursuits, allowing him to translate research into practical health solutions.

Collaborations

Jinqiu has collaborated with other skilled professionals in the field, including Minhua Chen and Yanfeng Zhang. These partnerships have fostered an environment of teamwork and innovation, leading to the successful development of groundbreaking patents in the pharmaceutical sector.

Conclusion

Jinqiu Wang's contributions to the realm of pharmaceutical innovations, particularly his work on GSK1278863, underline his role as a leading inventor in addressing critical health issues. His dedication and collaborative efforts with esteemed colleagues reaffirm the importance of innovation in the ongoing battle against anemia and other health challenges.

Profile summary based on public USPTO records.